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Streszczenie – Autorzy przedstawili opis rzadko obecnie spotykanego 
zespołu Lemierre’a. Zwrócono uwagę na etiologię, objawy, diagno-
stykę i leczenie. Niska częstotliwość występowania danej jednostki 
chorobowej może przyczynić się do niedostatecznej wiedzy persone-
lu na jej temat   lub jej braku. Ma to ogromny wpływ na postawienie 
prawidłowej diagnozy, jak i czas jej rozpoznania.  
Słowa kluczowe - zespół Lemierre’a, epidemiologia, objawy, lecze-
nie, rokowanie. 
 
Abstract – The authors have described a condition that nowadays is 
encountered only rarely, namely Lemierre’s syndrome. They paid 
attention to its aetiology, diagnostics and treatment. The low frequen-
cy of occurrence of a given disease classification can contribute to 
the personnel having insufficient knowledge about it or not having it 
at all. That has a crucial impact on coming up with a  correct diagno-
sis as well as on the time of recognizance. 
Key words - Lemierre’s syndrome, epidemiology, symptoms, treat-
ment, prognosis. 
 
 
I. INTRODUCTION 
 
emierre's syndrome develops most often after a sore throat 
with a complication of circumtonsillar abscess filled with 
pus and bacteria. On the bottom of the abscess, anaerobic bac-
teria that do not require oxygen like Fusobacterium necropho-
rum have conditions optimal to flourish. The bacteria leave the 
the abscess and head for the neighbouring jugular vein in the 
neck, where they form an infected clot. The clot is carried by 
the bloodstream to reach various organs, causing bacteremia.  
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Parts of the clot travel to the lungs as emboli blocking branch-
es of the pulmonary and bronchial arteries. That leads to 
shortness of breath, chest pain and severe pneumonia. Fuso-
bacteria are a normal physiological parts of the oropharyngeal 
flora. 
Sepsis caused by a throat infection was first described by 
Scottmuller in 1918. In 1936, André Lemierre published a 
series of 20 cases where throat infections were followed by 
confirmed anaerobic septicaemia. 18 of those patients died [2]. 
Lemierre’s syndrome is a relatively rare disease unit in mod-
ern-day medicine. Its high frequency had been observed before 
penicillin was introduced into therapies in the early 20
th
 centu-
ry. The present tendency to avoid antibiotics in the treatment 
of pharyngitis may lead to increased risk of this syndrome. In 
1997, 19 cases of Lemierre’s syndrome were described in 
Great Britain, whereas in 1999 the number rose to 34. The 
incidence rate is 0,8 cases per million in general population, 
which is the reason why Lemierre’s syndrome is nicknamed a 
“forgotten disease” [3]. The disease affects mainly young, 
healthy adults. 
 
II. PATHOGENESIS 
 
Fusobacterium necrophorum is an etiologic factor that oc-
curs in most of the cases of Lemierre’s syndrome. The Fuso-
bacterium necrophorum infection leads to Lemierre’s syn-
drome only in 1 per 400 cases [4].  
Lemierre’s disease is caused by Fusobacterium necropho-
rum in 81% of the cases, while the other 11% are caused by 
other species of Fusobacterium. Also, methicillin-resistant 
Staphylococcus aureus (MRSA) microbes can contribute to 
the development of Lemierre’s syndrome. Infrequently, such 
bacteria as Bacteroides fragilis, melaninogenicus, Peptostrep-
tococcus spp, Streptococcus microaerophile, Staphylococcus 
ureus and Eikenella corrodens were the cause of the disease 
[5]. 
Lemierre’s syndrome begins with an infection of head 
and/or neck area. Usually it is pharyngitis, occurring in 87,1% 
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 of the cases. The disease may also follow otitis, mastoiditis, 
sinusitis or mumps.  
During the primary infection, F. necrophorum  colonizes the 
infected area which expands in the peripharyngeal space. 
Then, the bacteria move to peritonsillar blood vessels, where 
they find their way to the internal jugular vein. There, a clot 
that contains the bacterial material if formed. What is more, 
that leads to an inflammation of that vein. As parts of the clot 
are separated from it, the infected embolic material is carried 
all over the organism, which may cause abscesses to form in 
distant organs and increase the risk of embolism. At first, the 
embolic material reaches pulmonary circulation capillaries. As 
a result, the most frequent location of abscess formation are 
lungs, followed by major joints (knee, hip, shoulder, elbow 
and sternoclavicular joints). In the lungs, the bacteria form 
abscesses, involve lymph nodes and cause necrosis in the lung 
tissue. Frequently, there is fluid in pleural cavities. What is 
more, the infected embolic material may deteriorate to muscle 
tissue, connective tissue, liver, spleen, kidneys and nervous 
system (causing, for that matter, meningitis and brain abscess-
es). 
Bacterial toxins such as lipopolysacharide (LPS) may disa-
ble cytokinogenesis and facilitate the development of sepsis.  
F. Necrophorum also produces hemagglutinin initiating plate-
let aggregation, which may lead to disseminated intravascular 
coagulation (DIC) with subsequent consumption thrombocyto-
penia. 
 
III. DIAGNOSIS 
Symptoms differ depending on each case, yet most of the 
time the illness begins with pharyngitis, fever and generalized 
weakness. Then, serious exhaustion is experienced and septic 
fevers occur. What follows is  lymphadenopathy; also, the 
neck becomes numb, swollen and sensitive. Usually, ab-
dominal pain, nausea, diarrhea and vomiting also occur. These 
symptoms can be observed for as long as between a few days 
and two weeks since the first symptoms occur [5]. 
The symptoms which point to the involvement of respiratory 
system are airlessness, coughing and  pleurodynia. Haemopty-
sis is observed as well, yet rather rarely. In case joints are in-
volved, also pain and other symptoms of arthritis. 
The symptoms of septic shock are hypotension, tach-
ycardia, oliguria and tachypnoe.  Numbness of the neck, head-
ache and photophobia may suggest  meningitis. Also, hepato-
megaly and splenomegaly  may occur, not necessarily caused 
by abscesses in liver and spleen, respectively [6]. 
Other symptoms include: headaches (unrelated to meningitis), 
muscle pains (general pain in the whole body), jaundice, lock-
jaw, lung field crackles (rales), friction rub as a symptom of 
pericarditis (rarely), cranial nerve palsy, Horner’s syndrome 
(myosis, ptosis, endophtalmus – occurring rarely).  
Diagnostics 
The range of laboratory and imaging examinations are de-
termined depending on the patient’s general condition. If phar-
yngitis persists and the aforementioned symptoms occur, 
health screening should be performed with regard to Lem-
ierre’s syndrome.  
Laboratory tests indicate bacterial infection with higher 
acute-phase protein level (CRP), increased erythrocyte sedi-
mentation rate (ESR) and leukocytes, especially  neutrophils. 
The level of platelets is usually higher than normal, although it 
can be too low as well. Liver and kidney parameters are gener-
ally abnormal. 
Thrombosis of the jugular vein may be exposed in ultra-
sound examination. Nevertheless, a newly formed clot may not 
be visible in the USG of jugular veins as its echogenicity is 
low. In such cases, a CT scan or MRI may prove to be more 
effective [3]. 
The X-ray or tomography may indicate fluid in pleural cavi-
ties, parenchymal densification within lung fields and abscess-
es. 
Bacterial cultures from blood, synovial fluid and other loca-
tions may enable the identification of the etiologic factor.  
The following disease units should be taken into account in 
differential diagnosis: Q fever, tuberculosis and pneumonia of 
some other aetiology. 
 
 
IV. TREATMENT AND PROGNOSIS  
 
 
Lemierre’s syndrome is usually treated by antibiotics ap-
plied intravenously. However, because a frequent cause of 
pharyngitis is a virus infection, antibiotics are not obligatory in 
the first line treatment [7].  
Fusobacterium necrophorum is highly susceptible to beta-
lactam antibiotics, metronidazole, clindamycin and third-
generation cephalosporins, whereas other Fusobacterium 
strains show different level of susceptibility to beta-lactams 
and clindamycin. Moreover, a co-infection by other microbes 
may occur in a given single case of the disease. Therefore, 
monotherapy  is not recommended for treating Lemierre’s 
syndrome. Usually, a penicillin antibiotic along with a beta-
lactamase  inhibitor (like clavulonic acid) and metronidazole 
are applied. Clindamycin can be applied in monotherapy [8]. 
When antibiotics fail, the formed abscesses need to removed 
surgically. Also, the clots must be removed from the internal 
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 jugular vein and antibiotics applied to the area of the infected 
clot. 
There are no unequivocal indications as far as anticoagulant 
therapy for Lemierre’s syndrome is concerned. The decisions 
are made depending on each patient’s condition. In case there 
are complications (meningitis, severe pneumonia), the disease 
may be resistant to treatment [6]. 
Mortality rate of Lemierre’s syndrome before the antibiotic 
era was very high, amounting to as much as 90%. Presently, as 
it can be timely diagnosed and the treatment can be quickly 
implemented, the mortality rate is between 6,4 and 15% [6]. 
Nevertheless, in the cases when the diagnosis is delayed, the 
mortality rate may be significantly higher
 
[9].
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